THE KPM GROUP DC LLC

Lobbying for MAHZI THERAPEUTICS · Focused on treating under‐served rare genetic neurodevelopmental disorders

Filing Registration

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Mar 30, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Priority review voucher (PRV) re-authorization, ICD-10 codes

Health Issues

Priority review voucher (PRV) re-authorization, ICD-10 codes

Science/Technology

Priority review voucher (PRV) re-authorization, ICD-10 codes

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.